Office-based management of nonmuscle invasive bladder cancer.
Bladder cancer is extremely common in the United States and extremely costly because of the high cost of surveillance. In some patients, office-based surveillance may be a safe, cost-reducing alternative. This article attempts to identify ideal candidates and highlights surveillance strategies that can be employed in an office-based setting.